News

Filter

Current filters:

EliquisXareltoRegulation

“Breakthrough Therapy” status for Portola’s andexanet alfa

25-11-2013

USA-based Portola Pharmaceuticals has been granted “Breakthrough Therapy” designation by the US Food…

andexanet alfaBayerBristol-Myers SquibbCardio-vascularEliquisNorth AmericaPharmaceuticalPortola PharmaceuticalsRegulationResearchXarelto

Bristol-Myers Squibb and Pfizer's Eliquis meets primary endpoints in Ph III VTE trial

01-07-2013

BayerBristol-Myers SquibbCardio-vascularEliquisJohnson & JohnsonPfizerPharmaceuticalRegulationXarelto

COMPANY SPOTLIGHT

Menarini

Back to top